Mary K. Moreland - Feb 28, 2023 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
EXECUTIVE VICE PRESIDENT
Signature
/s/ Mary K. Moreland by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Feb 28, 2023
Transactions value $
-$663,489
Form type
4
Date filed
3/2/2023, 06:45 PM
Previous filing
Feb 22, 2023
Next filing
Feb 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Tax liability -$591K -5.93K -6.31% $99.77 87.9K Feb 28, 2023 Direct
transaction ABT Common shares without par value Sale -$72.3K -717 -0.82% $100.77 87.2K Mar 1, 2023 Direct
holding ABT Common shares without par value 11.2K Feb 28, 2023 Profit Sharing Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2023.

Remarks:

The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).